Hovione Acquires ExtremoChem
November 28, 2023
Hovione has acquired ExtremoChem, a developer and commercializer of synthetic sugars for stabilizing biopharmaceuticals, to add functional materials to its CDMO platform. Financial terms were not disclosed; Hovione said the acquisition enhances its formulation, particle engineering and stabilization capabilities and will support wider market adoption of ExtremoChem’s sugars.
- Buyers
- Hovione
- Targets
- ExtremoChem
- Industry
- Biotechnology
- Location
- Portugal
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.